Biocompatibility of two apatite cements

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Calcium phosphate cements (CPCs) are widely used bone void fillers.
• Evaluating novel CPC formulations like G-5 and G-6 alongside established materials such as Super-EBA is crucial for clinical application.
• Understanding material biocompatibility and osteogenic potential guides the development of advanced bone graft substitutes.

Purpose of the Study:

• To assess the biocompatibility and osteogenic potential of two novel calcium phosphate cements (G-5 and G-6) and Super-EBA.
• To compare the host tissue response to subcutaneous and intraosseous implantation of these materials in a rat model.
• To determine the long-term effects of these biomaterials on surrounding tissues over 60 days.

Main Methods:

• Subcutaneous and intraosseous implantation of G-5, G-6, and Super-EBA in 90 rats.
• Microscopic evaluation of tissue reactions at 15, 30, and 60 days post-implantation.
• Histological analysis to assess inflammation, foreign body response, resorption, and bone formation.

Main Results:

• Super-EBA demonstrated excellent biocompatibility in both soft and hard tissues.
• G-5 exhibited high biocompatibility, with evidence of resorption and bone replacement at intraosseous sites.
• G-6 induced moderate inflammation and a foreign body giant cell response.
• No significant osteogenesis or dystrophic calcification was observed at subcutaneous implantation sites for any material.

Conclusions:

• G-5 shows promising biocompatibility and osteogenic potential for intraosseous applications.
• G-6 elicits a significant inflammatory response, suggesting limitations for bone regeneration.
• Super-EBA is a well-tolerated biomaterial for bone defect management.
• Further research is needed to optimize CPC formulations for enhanced bone healing and reduced inflammatory reactions.